Top 4 Large-Cap Stocks In The Drug Manufacturers Industry With The Highest ROE

Loading...
Loading...
Below are the top large-cap drug manufacturers stocks on the NYSE and the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at
Shire plcSHPG
is 50.50%. Shire's PEG ratio is 1.01. The trailing-twelve-month return on equity at
GlaxoSmithKline plc GSK
is 50.00%. GlaxoSmithKline's EPS for the same period is $1.69. The trailing-twelve-month return on equity at
AbbVie Inc. ABBV
is 43.50%. AbbVie's revenue for the same period is $19.96 billion. The trailing-twelve-month return on equity at
Merck & Co. Inc. MRK
is 24.80%. Merck's EPS growth forecast for the next year is 12.59%.
Posted In: Trading IdeasDrug ManufacturersLarge-CapROE
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...